Deborah Caswell, NP
Adult Health · Santa Fe, NMNPI 1578546628
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,568 of the $1,831 with a category attached, or 85.6%. 12 manufacturers reported payments, led by Smith+Nephew at 55.2% of the total.
Across 96 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- AbbVie$217
- Integra Lifesciences Corporation$176
- Organogenesis Inc.$118
- KCI USA, Inc.$81
- Paratek Pharmaceuticals, Inc.$62
- plus $166 from 6 others
What the payments were for
- Speaking & faculty fees$151%
- Travel & lodging$724%
- Food & beverage$1,56886%
- Other$17610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 61 | $1,011 |
| AbbVie | 12 | $217 |
| Integra Lifesciences Corporation | 1 | $176 |
| Organogenesis Inc. | 5 | $118 |
| KCI USA, Inc. | 4 | $81 |
| Paratek Pharmaceuticals, Inc. | 3 | $62 |
| Solventum Corporation | 3 | $57 |
| Hydrofera LLC | 2 | $38 |
| Reprise Biomedical, Inc. | 2 | $25 |
| Kerecis Limited | 1 | $17 |
| Mckesson Medical-surgical, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACell$176
How this compares
$1,831 in reported general payments places this provider in the 80th percentile of 52 adult health providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 25 | $598 |
| Cefdinir | 29 | $423 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $300 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $229 |
| Tramadol Hcl | 13 | $138 |
| Oxycodone Hcl | 13 | $94 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $77 |
| Pregabalin | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other adult health in Santa Fe
- Sarah HobongwanaSanta Fe$1K
- Ilango DharmarajanSanta Fe$572
- Holly Purcell-CallinSanta Fe$249
- Terese SelvageSanta Fe$189
- Sheila HundleySanta Fe$136
- Elizabeth EvansAlbuquerque$9K
- Leslie DorkAlbuquerque$7K
- Stephanie MahootyAlbuquerque$6K
- Debra NarcisseAlbuquerque$5K
- Kimberly MillerLas Cruces$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.